Business Context and Reporting Period
This Form 8-K is a current report filed by Pavmed Inc. (PAVM) on February 11, 2022. The filing primarily addresses corporate governance changes, specifically the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on personnel and governance rather than financial performance.
Material Changes
- Board Appointment: Effective February 11, 2022, Joan B. Harvey was appointed as a Class C director.
- Committee Assignments: Ms. Harvey will join the Audit and Compensation Committees.
- Compensation Arrangement: Ms. Harvey was granted a ten-year option to purchase 179,350 shares of common stock at an exercise price of $2.05 per share. The option vests in 12 quarterly installments starting March 31, 2022.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of material risks and contingencies. Management commentary is limited to the professional background of the new director, highlighting over two decades of healthcare leadership experience, including her current role as President of Care Solutions for Evernorth (Cigna Corporation).
Investor Verification Checklist
- Verify the vesting schedule and exercise price of the 179,350 stock options granted to Joan B. Harvey.
- Confirm the impact of the new director's appointment on the composition of the Audit and Compensation Committees.
- Review the attached press release (Exhibit 99.1) for additional context on the appointment.